Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) CEO Dagi Shahar Ben-Noon Acquires 14,093 Shares of Company Stock

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX) CEO Dagi Ben-Noon bought 14,093 shares of the business’s stock in a transaction on Tuesday, October 13th. The stock was purchased at an average price of $1.49 per share, for a total transaction of $20,998.57. Following the purchase, the chief executive officer directly owned 14,093 shares in the company, valued at approximately $20,998.57. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Dagi Shahar Ben-Noon also recently made the following trade(s):

• On Friday, October 9th, Dagi Ben-Noon purchased 18,181 shares of Inspira Technologies OXY B.H.N. stock. The shares were purchased at an average cost of $1.67 per share, with a total value of $30,362.27.
• On Monday, September 28th, Dagi Ben-Noon purchased 168,894 shares of Inspira Technologies OXY B.H.N. stock. The shares were acquired at an average cost of $0.71 per share, with a total value of $119,914.74.

Inspira Technologies OXY B.H.N. Price Performance

Shares of QTEX opened at $1.58 on Wednesday. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.00 and a quick ratio of 1.62. Inspira Technologies OXY B.H.N. Ltd has a twelve month low of $0.28 and a twelve month high of $3.85. The business’s 50 day simple moving average is $0.98.

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) last announced its quarterly earnings data on Thursday, September 24th. The company reported ($0.07) EPS for the quarter. The firm had revenue of $0.78 million for the quarter.

Inspira Technologies OXY B.H.N. declared that its board has authorized a share repurchase plan on Monday, June 22nd that allows the company to repurchase 2,000,000,000,000 outstanding shares. This repurchase authorization allows the company to buy up to 5.6% of its shares through open market purchases. Share repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Wall Street Zen cut shares of Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a research report on Saturday, August 8th. Weiss Ratings downgraded shares of Inspira Technologies OXY B.H.N. from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

About Inspira Technologies OXY B.H.N.

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.

Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.